Search

everythinglearnresearchcommunity

for

Search:↓

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Ruxolitinib can help regrow hair in severe alopecia areata.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

Baricitinib may not always prevent relapse in alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Abrocitinib may effectively treat Lichen Planopilaris.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tretinoin is used topically to treat acne, skin aging, and various skin conditions.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.